» Articles » PMID: 31060424

Fusaric Acid-induced Promoter Methylation of DNA Methyltransferases Triggers DNA Hypomethylation in Human Hepatocellular Carcinoma (HepG2) Cells

Overview
Journal Epigenetics
Specialty Genetics
Date 2019 May 8
PMID 31060424
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Fusaric acid (FA), a mycotoxin contaminant of maize, displays toxicity in plants and animals; however, its epigenetic mechanism is unknown. DNA methylation, an epigenetic modification that regulates gene expression, is mediated by DNA methyltransferases (DNMTs; DNMT1, DNMT3A, and DNMT3B) and demethylases (MBD2). The expression of DNMTs and demethylases are regulated by promoter methylation, microRNAs (miR-29b) and post-translational modifications (ubiquitination). Alterations in these DNA methylation modifying enzymes affect DNA methylation patterns and offer novel mechanisms of FA toxicity. We determined the effect of FA on global DNA methylation as well as a mechanism of FA-induced changes in DNA methylation by transcriptional (promoter methylation), post-transcriptional (miR-29b) and post-translational (ubiquitination) regulation of DNMTs and MBD2 in the human hepatocellular carcinoma (HepG2) cell line. FA induced global DNA hypomethylation ( < 0.0001) in HepG2 cells. FA decreased the mRNA and protein expression of DNMT1 ( < 0.0001), DNMT3A ( 0.0001), and DNMT3B ( 0.0001) by upregulating miR-29b ( 0.0001) and inducing promoter hypermethylation of ( 0.0001) and ( < 0.0001). FA decreased the ubiquitination of DNMT1 ( 0.0753), DNMT3A ( 0.0008), and DNMT3B ( < 0.0001) by decreasing ( < 0.0001) and ( < 0.0001). FA also induced promoter hypomethylation ( < 0.0001) and increased MBD2 expression ( < 0.0001). Together these results indicate that FA induces global DNA hypomethylation by altering promoter methylation, upregulating miR-29b, and increasing MBD2 in HepG2 cells.

Citing Articles

Targeting microRNA methylation: Innovative approaches to diagnosing and treating hepatocellular carcinoma.

Sufianov A, Agaverdiev M, Mashkin A, Ilyasova T Noncoding RNA Res. 2025; 11():150-157.

PMID: 39829957 PMC: 11742574. DOI: 10.1016/j.ncrna.2024.12.002.


Patulin alters alpha-adrenergic receptor signalling and induces epigenetic modifications in the kidneys of C57BL/6 mice.

Mazibuko M, Ghazi T, Chuturgoon A Arch Toxicol. 2024; 98(7):2143-2152.

PMID: 38806716 PMC: 11168996. DOI: 10.1007/s00204-024-03728-z.


Fusaric acid inhibits proliferation and induces apoptosis through triggering endoplasmic reticulum stress in MCF-7 human breast cancer cells.

Zhang J, Yuan H, Li W, Chen S, Liu S, Li C Mycotoxin Res. 2023; 39(4):347-364.

PMID: 37400696 DOI: 10.1007/s12550-023-00497-z.


Hypermethylation of in CD4 T cells is associated with the disease activity of rheumatoid arthritis.

Hu Y, Xu B, He J, Shan H, Zhou G, Wang D Front Immunol. 2023; 14:1104881.

PMID: 36845150 PMC: 9947360. DOI: 10.3389/fimmu.2023.1104881.


Ibuprofen promotes p75 neurotrophin receptor expression through modifying promoter methylation and N6-methyladenosine-RNA-methylation in human gastric cancer cells.

Jin H, Wu Z, Tan B, Liu Z, Zu Z, Wu X Bioengineered. 2022; 13(6):14595-14604.

PMID: 35758042 PMC: 9342148. DOI: 10.1080/21655979.2022.2092674.


References
1.
Beard C, Possemato R, TUDOR M, Fambrough D, Csankovszki G, Dausman J . Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat Genet. 2001; 27(1):31-9. DOI: 10.1038/83730. View

2.
Ogata S, Inoue K, Iwata K, Okumura K, Taguchi H . Apoptosis induced by picolinic acid-related compounds in HL-60 cells. Biosci Biotechnol Biochem. 2002; 65(10):2337-9. DOI: 10.1271/bbb.65.2337. View

3.
Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

4.
Detich N, Theberge J, Szyf M . Promoter-specific activation and demethylation by MBD2/demethylase. J Biol Chem. 2002; 277(39):35791-4. DOI: 10.1074/jbc.C200408200. View

5.
Stack Jr B, Hansen J, Ruda J, Jaglowski J, Shvidler J, Hollenbeak C . Fusaric acid: a novel agent and mechanism to treat HNSCC. Otolaryngol Head Neck Surg. 2004; 131(1):54-60. DOI: 10.1016/j.otohns.2004.02.038. View